Day: June 19, 2020

West Palm Beach-Boca Raton, FL – A recognized leader in the financial services industry, Jack began his professional career in 1981 with The Guardian Life Insurance Company. In his first year with The Guardian, Jack was named “Rookie of the Year”. Heis a current member of the “Top of the Table”, a 31 time qualifier of Guardian’s prestigious President’s Council, and a 22 year Guardian Centurion Club Member. Jack is currently a Senior Sales Consultant and is a member of the Newark Chapter of the National Association of Insurance and Financial Advisors; the Monmouth County, New Jersey Society of Financial Service Professionals, has been a 28 time member of The Guardian’s “Executive Committee”, and is currently serving as the Second Vice President of the 2018-19 Executive Committee. In 1995, Jack was elected by his peers as President...

VANCOUVER, British Columbia, June 19, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, continues to highlight the scientific merit of its ketamine treatments for Major Depressive Disorder (MDD) while demonstrating rapid onset efficacy and safety of its treatment processes. To this accord, the Company is proud to announce that its Chief Executive Officer, Dr. Roger McIntyre, and the Canadian Rapid Treatment Centre of Excellence (the “CRTCE”) have been recently published in two peer reviewed study journals (the “Peer Reviewed Studies”) focusing on ketamine’s safety, tolerability and effectiveness:Safety and tolerability of IV ketamine in adults with major depressive or bipolar...

Good morning,Please find below the press release issued today.Best regards,Michele Moore DuhenGlobal PR Manager | Group Marketing & CommunicationsCapgemini Group | LondonTel.: +44 3709 053408Email: Michele.MooreDuhen@capgemini.com_____________________________Press contact:Michele Moore DuhenTel.: +44 370 905 3408Email: michele.mooreduhen@capgemini.com  Ministry of Defence in the UK chooses Capgemini to run itsIT Service CenterLondon, Paris, June 19, 2020 – Capgemini and the UK’s Ministry of Defence (MOD) have announced a five-year contract for the provision of the MOD’s IT Service Center. Under this agreement, Capgemini will work with the MOD’s Defence Digital unit to provide the next generation of services aligned to its needs both now and in the future.The Service Center is at the core of Operational Service Management (OSM), which...

 Bonjour,Vous trouverez ci-après le communiqué de presse diffusé ce jour.Bien cordialement,Florence LièvreGlobal PR Manager | Group Marketing & CommunicationsCapgemini Group | ParisTel.: +33 1 47 54 50 71Email : florence.lievre@capgemini.com_____________________ Contact presse :Florence LièvreTél. : +33 1 47 54 50 71E-mail : florence.lievre@capgemini.comLe ministère de la Défense du Royaume-Uni confie la gestionde son centre de services IT à CapgeminiLondres, Paris, le 19 juin 2020 – Capgemini et le ministère de la Défense (MOD) britannique annoncent la signature d’un contrat de cinq ans pour la gestion du centre de services IT du ministère. Dans le cadre de cet accord, Capgemini collaborera avec la division Defence Digital du MOD pour déployer de nouveaux services répondant à ses besoins actuels et futurs.Ce centre de services est...

First-ever granted patent on oral administration of anti-CD3 monoclonal antibodies for immunotherapiesTransformational oral formulation technologies applicable to other antibodiesThis announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.NEW YORK and LONDON, June 19, 2020 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq: TLSA; AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, announces that the United States Patent and Trademark Office (“USPTO”) has granted a patent covering its proprietary platform technology for the oral administration of Foralumab, its proprietary fully human monoclonal antibody, and all other anti-CD3 monoclonal antibodies (mAb). The CD3 (cluster of differentiation...

Telia Lietuva, AB together with other shareholders – UAB Bitė Lietuva and UAB Tele 2 – sold all shares of UAB Mobilieji Mokėjimai to SEPAxpress FS, UAB, that enables Payment Service Providers and corporates to access the SEPA payment market while also providing value added services in cooperation with payment industry partners across Europe.Three Lithuanian mobile operators acquired shares of UAB Mobilieji Mokėjimai in December 2017 in equal stakes of 33.3 per cent. Until 18 May 2020 the undertaking was providing mobile payment services under MoQ brand.Darius Džiaugys,Head of Investor Relations,tel. +370 5 236 7878,e-mail: darius.dziaugys@telia.lt

Telia Lietuva, AB kartu su kitais akcininkais – UAB „Bitė Lietuva“ ir UAB „Tele 2” – pardavė visas UAB „Mobilieji mokėjimai“ akcijas SEPAexpress FS, UAB. SEPAexpress FS teikia prisijungimo prie SEPA mokėjimų sistemos bei papildomos vertės paslaugas mokėjimo paslaugų teikėjams ir verslo įmonėms bendradarbiaudama su kitais mokėjimų rinkos partneriais Europos šalyse.Trys Lietuvos mobiliojo ryšio operatoriai lygiomis dalimis (po 33,3 proc.) UAB „Mobilieji mokėjimai“ akcijų įsigijo 2017 m. gruodį. Įmonė iki 2020 m. gegužės 18 d. teikė mobiliųjų mokėjimų paslaugas su MoQ prekės ženklu.Darius Džiaugys,Ryšių su investuotojais vadovas,tel. (8 5) 236 7878,el. p. darius.dziaugys@telia.lt.

Steven van Rijswijk to succeed Ralph Hamers as CEO of INGING announced today that Steven van Rijswijk, currently member of the Executive Board and chief risk officer of ING, will succeed Ralph Hamers as CEO and chairman of the Executive Board. The Supervisory Board has appointed Steven van Rijswijk effective 1 July 2020. As announced earlier, Ralph Hamers will leave ING to join UBS, where he will become CEO later in the year.Hans Wijers, chairman of the Supervisory Board of ING said: “We are very pleased to appoint Steven, following a broad and rigorous selection process. With almost 25 years at ING, of which three on the Executive Board, Steven has shown to have the right combination of experience, leadership skills and deep understanding of our business to lead ING into the next phase of our strategic direction. Again, we want to thank...

      ·Phase III IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone compared to current standard-of-care (abiraterone and prednisone/prednisolone alone) plus placebo met its co-primary endpoint of radiographic progression free survival (rPFS) in patients with PTEN loss tumoursReferences [1] Yang J, et al. Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer. 2019; 18(1).[2] Crumbaker M, et al. AR Signaling and the PI3K pathway in prostate cancer. Cancers (Basel). 2017; 9(4):34.[3] Wang Y, et al. Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/AKT pathway in prostate cancer. Current Cancer Drug Targets. 2007; 7(6), 591-604.[4] De Bono JS, et al. Randomized phase ii study evaluating AKT blockade with ipatasertib, in combination...

PRESS RELEASE 19 JUNE 2020Italeaf: the subsidiary algoWatt put into operation the Purify groundwater remediation and industrial liquid waste treatment plantThe new environmental asset put into service in Umbria, in the eco-industrial park of Nera Montoro (TR) and is authorized to treat 438,000 cubic meters per year of groundwater and 58,000 tons per year of liquid waste.Plant owned by Purify Srl, a JV between algoWatt and ATP Project & Constructions, Total investment of approximately Euro 9 millionItaleaf SpA, holding company and first Italian company builder active in the cleantech and smart innovation sectors, listed on the NASDAQ First North Growth Market of the Stockholm Stock Exchange, announces that the subsidiary algoWatt, GreenTech Solutions company listed on Borsa Italiana’s electronic stock exchange (MTA) announces...